Here's an important article about the Lariat device for closing off the left atrial appendage. Back in March, we reported from the American College of Cardiology that Dr. Natale's group had reported finding that about one-fourth of Lariat patients had leaks (see bottom of page), some with bad results such as strokes. This new article tells …
There was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …
